Published in Eur J Epidemiol on August 09, 2009
The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26
The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design. Eur J Epidemiol (2010) 0.96
New studies, technology, and the progress of epidemiology. Eur J Epidemiol (2010) 0.81
Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany. J Cancer Res Clin Oncol (2011) 0.79
The descriptive epidemiology of gastric cancer in Central America and comparison with United States Hispanic populations. J Gastrointest Cancer (2015) 0.77
Basis for molecular diagnostics and immunotherapy for esophageal cancer. Expert Rev Anticancer Ther (2016) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Gastric carcinoma. N Engl J Med (1995) 5.77
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer (1990) 3.18
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol (2000) 2.97
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol (2001) 2.56
Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut (2002) 1.84
Esophageal and gastric carcinoma in Norway 1958-1992: incidence time trend variability according to morphological subtypes and organ subsites. Int J Cancer (1997) 1.84
Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer (2002) 1.48
Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg (1993) 1.40
Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer (2002) 1.37
Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev (1996) 1.37
The rising incidence of gastric cardia cancer. J Natl Cancer Inst (1999) 1.29
Case-control study on stomach cancer in Germany. Int J Cancer (1991) 1.22
Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992. Int J Epidemiol (1996) 1.10
Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland. Br J Cancer (2000) 1.06
Incidence of cancer of oesophagus, cardia and stomach in Denmark. Eur J Cancer Prev (1992) 1.05
Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol (2002) 1.05
The time trend and age-period-cohort effects on incidence of adenocarcinoma of the stomach in Connecticut from 1955-1989. Cancer (1993) 1.04
Rising incidence of oesophageal adenocarcinoma in men in Australia. J Gastroenterol Hepatol (1998) 0.99
Attributable risks for oesophageal cancer in northern Italy. Eur J Cancer (1992) 0.99
Incidence trends in oesophageal and proximal gastric carcinoma in Victoria. Aust N Z J Surg (1996) 0.97
Linking Helicobacter pylori to gastric cancer. Nat Med (2000) 0.97
Trends in registered incidence of oesophageal and stomach cancer in the Oxford region, 1974-88. Eur J Cancer Prev (1992) 0.94
Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997. Eur J Surg (2001) 0.93
Recent time trends in cancer of the oesophagus and gastric cardia in the region of Calvados in France, 1978-1995: a population based study. Eur J Cancer Prev (1999) 0.86
Changing pattern of oesophageal cancer incidence in France. Int J Epidemiol (1994) 0.82
Esophageal and gastric carcinoma in Vaud, Switzerland, 1976-1994. Int J Cancer (1998) 0.75
Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma. Swiss Med Wkly (2003) 0.75
[Barrett's esophagus: diagnosis and therapy]. Praxis (Bern 1994) (2005) 0.75
Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology (2005) 1.96
Human intestinal spirochetosis--a review. Ger Med Sci (2010) 1.25
Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr (2003) 0.91
Role of the different isoforms of cyclooxygenase and nitric oxide synthase during gastric ulcer healing in cyclooxygenase-1 and -2 knockout mice. Am J Physiol Gastrointest Liver Physiol (2005) 0.91
Development, characterization, and use of a fetal skin cell bank for tissue engineering in wound healing. Cell Transplant (2006) 0.88
Gastrin-releasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments. J Clin Endocrinol Metab (2005) 0.82
Cytopathology of the nasal mucosa in chronic exposure to diesel engine emission: a five-year survey of Swiss customs officers. Environ Health Perspect (2003) 0.80
Local pathogenic bacteria in allergic rhinitis: a novel concept of its pathogenesis. ORL J Otorhinolaryngol Relat Spec (2003) 0.76
[Eosinophilic granuloma of the mandible--a case report]. Schweiz Monatsschr Zahnmed (2009) 0.75